Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Hemp, Inc. operates in the healthcare sector, focusing on the production and distribution of hemp-based products, including CBD oils and dietary supplements. The company has positioned itself as a leader in the hemp industry, particularly in the United States, leveraging its extensive cultivation and processing capabilities to capture a growing market demand for hemp-derived products.
Hemp, Inc. generates revenue primarily through the sale of hemp-derived CBD products, which are in high demand due to increasing consumer interest in natural health solutions. The company benefits from a strong brand presence and established distribution channels, allowing it to maintain pricing power despite competitive pressures.
Changes in federal and state regulations regarding hemp and CBD products
Market demand for natural health products, particularly CBD
Partnerships with retailers for product distribution
Advancements in hemp cultivation technology
Regulatory changes that could limit the sale or production of hemp products
Market saturation as more competitors enter the CBD space
Increased competition from established pharmaceutical companies entering the CBD market
Emerging brands with innovative products and marketing strategies
High debt levels could strain liquidity and limit operational flexibility
Negative operating margins raise concerns about long-term sustainability
moderate - The demand for hemp products is somewhat correlated with consumer spending, but the essential nature of health products provides some insulation during economic downturns.
The company's financing costs are impacted by interest rates, as higher rates could increase borrowing costs for expansion and operational activities, potentially affecting profitability.
minimal - The company does not heavily rely on credit for operations, though its high debt/equity ratio suggests some vulnerability to credit market conditions.
growth - Investors are likely attracted to the high revenue growth potential in the expanding CBD market.
high - The stock has exhibited extreme volatility, with a 4900% return over the past year, indicating speculative trading behavior.
